Maria Chiara Monti Selected Research

Alcoholic Fatty Liver

1/2019

Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Chiara Monti Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 06/2010
8	Inflammation (Inflammations) 10/2019 - 01/2006
4	Cholestasis 01/2020 - 01/2012
4	Insulin Resistance 10/2019 - 01/2017
4	Rheumatoid Arthritis 10/2012 - 01/2006
3	Fatty Liver 01/2022 - 01/2017
3	Obesity 01/2019 - 08/2018
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2012 - 11/2009
3	Septic Shock (Toxic Shock Syndrome) 10/2012 - 11/2009
3	Asthma (Bronchial Asthma) 10/2012 - 11/2009
2	Melanoma (Melanoma, Malignant) 01/2022 - 12/2020
2	Adenocarcinoma of Lung 09/2021 - 04/2021
2	Hyperammonemia 01/2020 - 11/2011
2	Fibrosis (Cirrhosis) 10/2019 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 09/2012
1	Fabry Disease (Fabry's Disease) 05/2022
1	Wounds and Injuries (Trauma) 02/2022
1	Disease Progression 01/2022
1	Vascular System Injuries 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Pathologic Processes 04/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Hypercholesterolemia 01/2020
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020
1	Dysbiosis 10/2019
1	Body Weight (Weight, Body) 10/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 04/2019
1	Alcoholic Fatty Liver 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Morbid Obesity 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Chronic Disease (Chronic Diseases) 12/2018

Drug/Important Bio-Agent (IBA)

8	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2012
7	LigandsIBA 04/2021 - 11/2011
4	Pharmaceutical PreparationsIBA 05/2022 - 04/2014
4	Biological ProductsIBA 02/2022 - 12/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2014
4	oleocanthalIBA 06/2015 - 07/2011
3	CholesterolIBA 01/2022 - 01/2017
3	Olive OilIBA 07/2013 - 07/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2022 - 01/2006
2	pembrolizumabIBA 01/2022 - 12/2020
2	NivolumabIBA 01/2022 - 12/2020
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 12/2020
2	LipidsIBA 01/2022 - 01/2006
2	sphingosine kinaseIBA 09/2021 - 04/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2021 - 04/2021
2	arzanolIBA 01/2021 - 11/2018
2	isothiocyanic acidIBA 01/2020 - 01/2015
2	obeticholic acidIBA 01/2020 - 10/2019
2	FructoseIBA 10/2019 - 01/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 01/2015
2	EnzymesIBA 11/2018 - 01/2006
2	BAR502IBA 01/2017 - 01/2015
2	Secretory Phospholipases A2IBA 10/2012 - 11/2009
2	Phospholipases AIBA 10/2012 - 11/2011
1	alpha-Galactosidase (Beano)IBA 05/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Benzo(a)pyreneIBA 09/2021
1	Phosphotransferases (Kinase)IBA 09/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 09/2021
1	CytosineIBA 04/2021
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2021
1	GuanosineIBA 04/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2021
1	SphingolipidsIBA 04/2021
1	CeramidasesIBA 04/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	AntibodiesIBA 12/2020
1	Programmed Cell Death 1 ReceptorIBA 12/2020
1	CTLA-4 AntigenIBA 12/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020
1	Adenosine Monophosphate (AMP)IBA 12/2020
1	ProteomeIBA 01/2020
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 01/2020
1	phomoxanthone AIBA 01/2020
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2020
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	muricholic acidIBA 10/2019
1	compound 20IBA 04/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2019
1	Axl Receptor Tyrosine KinaseIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Clodronic Acid (Clodronate)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	Gemcitabine FDA Link 01/2019

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Ligation 01/2020 - 01/2012
1	Immunotherapy 01/2022
1	Liver Transplantation 04/2019
1	Gastrectomy 01/2019
1	Bariatric Surgery 01/2019